Tools · Private company · Oklahoma City, OK, US
Progentec Diagnostics, Inc.
Track this companyFree. Adds Progentec Diagnostics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials2
- Mobile Study to Measure and Predict Lupus Disease Activity Using Digital SignalsUNKNOWN · started Apr 28, 2020ClinicalTrials.gov NCT04449653 · fetched Nov 12, 2026
- Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to ClinicUNKNOWN · started May 31, 2019ClinicalTrials.gov NCT04018222 · fetched Nov 12, 2026
NIH awards3
- Commercialization Readiness of Immune Mediator Based Blood Tests that Inform Concurrent and Future Clinical Disease Activity in Systemic Lupus Erythematosus (SLE)Fiscal year 2026 · $895.1KNIH RePORTER 5SB1AI184309-03 · fetched Nov 12, 2026
- Commercialization Readiness of Immune Mediator Based Blood Tests that Inform Concurrent and Future Clinical Disease Activity in Systemic Lupus Erythematosus (SLE)Fiscal year 2025 · $895.1KNIH RePORTER 5SB1AI184309-02 · fetched Nov 12, 2026
- Commercialization Readiness of Immune Mediator Based Blood Tests that Inform Concurrent and Future Clinical Disease Activity in Systemic Lupus Erythematosus (SLE)Fiscal year 2024 · $895.1KNIH RePORTER 1SB1AI184309-01 · fetched Nov 12, 2026